Cellular and Molecular Gastroenterology and Hepatology · 2021 · 43 citations · 27 references
MedicineOncologyPharmacologyApoptosisChemotherapyGastrointestinal OncologyGastrointestinal InflammationGastrointestinal ToxicityMucosal InflammationMucositis ManagementMucositis PreventionMucositis TreatmentAntineoplastic Drug TherapyDrug-induced Mucosal InjuryEpithelial ApoptosisIntestinal Barrier IntegrityIntestinal Mucosal InjuryMucosal ProtectionMucositis ProphylaxisPrevention Of Chemotherapy-induced Mucositis
BACKGROUND & AIMS: Intestinal mucositis, a severe complication of antineoplastic therapeutics, is characterized by mucosal injury and inflammation in the small intestine. Therapies for the prevention and treatment of this disease are needed. We investigated whether 2'-fucosyllactose (2'-FL), an abundant oligosaccharide in human milk, protects intestinal integrity and ameliorates intestinal mucositis. METHODS: A mouse small intestinal epithelial (MSIE) cell line, mouse enteroid cultures, and human gastrointestinal tumor cell lines (AGS and HT29) were co-treated with the chemotherapy agent 5-fluorouracil (5-FU) and 2'-FL. Mice were injected intraperitoneally with 5-FU to induce intestinal mucositis. 2'-FL was administered in the drinking water to mice before (pretreatment) or concurrently with 5-FU injection. Body weight and pathologic changes were analyzed. RESULTS: 2'-FL alleviated 5-FU inhibition of cell growth in MSIE cells, but not in AGS and HT29 cells. The 5-FU-induced apoptosis in MSIE cells and enteroids was suppressed by 2'-FL. Compared with 5-FU treatment alone, 2'-FL pretreatment protected against body weight loss, and ameliorated inflammation scores, proinflammatory cytokine production, shortening of villi, epithelial cell apoptosis, goblet cell loss, and tight junctional complex disruption in the small intestine. 2'-FL concurrent treatment had less of an effect on intestinal mucositis than 2'-FL pretreatment. Interestingly, no effect of 2'-FL was observed on 5-FU-induced S-phase arrest in MSIE, AGS, and HT29 cells. Neither pretreatment nor concurrent treatment with 2'-FL affected 5-FU-induced inhibition of proliferation in MSIE cells. CONCLUSIONS: This study shows a novel direct effect of 2'-FL in protecting small intestinal epithelial cells against apoptosis stimulated by 5-FU, which may contribute to prevention of 5-FU-induced intestinal mucositis.
27
The Intestinal Epithelium: Central Coordinator of Mucosal Immunity
Joannie M. Allaire, Shauna M. Crowley, Sun‐Young Chang et al. · Trends in Immunology · 2018 · 882 citations
Chemotherapy‐driven dysbiosis in the intestinal microbiome
Emmanuel Montassier, Thomas Gastinne, Pajau Vangay et al. · Alimentary Pharmacology & Therapeutics · 2015 · 499 citations · Full text
R Whitehead, P E VanEeden, Mark Noble et al. · Proceedings of the National Academy of Sciences · 1993 · 366 citations · Full text